USA: A new study published in JAMA Network Open suggests that glucagon-like peptide-1 receptor agonists (GLP-1RAs) may offer ...

SkinCeuticals is betting on the GLP-1 market. On Monday, the medical-grade skin care revealed the launch of its A.G.E. Interrupter Ultra Serum, $185, which was developed for and tested on GLP-1 weight ...

Glucagon-like peptide-1 (GLP-1) inhibitors have proven effective in preventing cardiovascular events, leading to experts ...

GLP-1s are bringing many changes to people's lives. An unexpected and less welcome one? A newfound aversion to meat and other ...

The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity ...

The number of U.S. adults that are aware of GLP-1 drugs used for weight loss, such as Ozempic and Wegovy, has jumped ...

Studies found that glucagon-like peptide-1 (GLP-1) receptor agonists were valuable tools in improving outcomes and survival ...

Proposed experiment would allow states and Medicare drug plans to cover GLP-1 drugs like Ozempic and Wegovy for obesity, The ...

Use of GLP-1s, especially semaglutide and liraglutide, may increase risk for nonarteritic anterior ischemic optic neuropathy ...

In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...

Related: ShopMy's New Consumer Shopping Platform Prioritizes Human Recommendations Over Algorithms Related: See the Official ...

The demand for GLP-1 medications is only increasing. As employees seek better health benefits, employers who act now will set ...